Inhibitor of 2', 5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
D015088:2',5'-Oligoadenylate Synthetase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000241:Adenosine / Q000494:pharmacology; D002460:Cell Line; D003070:Coformycin / Q000031:analogs & derivatives / Q000494:pharmacology*; D003838:Deoxyadenine Nucleotides / Q000494:pharmacology; D003839:Deoxyadenosines / Q000494:pharmacology*; D004790:Enzyme Induction / Q000187:drug effects; D006710:Homocysteine / Q000031:analogs & derivatives / Q000494:pharmacology; D006801:Humans; D007370:Interferon Type I / Q000494:pharmacology*; D015649:Pentostatin; D012263:Ribonucleosides / Q000494:pharmacology*; D013601:T-Lymphocytes / Q000187:drug effects / Q000201:enzymology*; D014740:Vidarabine / Q000494:pharmacology
D003838:Deoxyadenine Nucleotides; D003839:Deoxyadenosines; D007370:Interferon Type I; D012263:Ribonucleosides; D006710:Homocysteine; D003070:Coformycin; D015649:Pentostatin; C007957:homocysteine thiolactone; D015088:2',5'-Oligoadenylate Synthetase; D014740:Vidarabine; D000241:Adenosine; C026600:2'-deoxyadenosine triphosphate